About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [508 citations: 101–200 of 484 articles]

Articles published in Prostate Cancer have been cited 508 times. The following is a list of the 484 articles that have cited the articles published in Prostate Cancer.

  • William Tabayoyong, and Robert Abouassaly, “Prostate Cancer Screening and the Associated Controversy,” Surgical Clinics of North America, 2015. View at Publisher · View at Google Scholar
  • Hayato Urushima, Yukiko Inomata-Kurashiki, Kazuo Nishimura, Ryoko Sumi, Iichiro Shimomura, Norio Nonomura, Toshinori Ito, and Kazuhisa Maeda, “The effects of androgen deprivation therapy with weight management on serum aP2 and adiponectin levels in prostate cancer patients,” The Aging Male, pp. 1–5, 2015. View at Publisher · View at Google Scholar
  • Arachk de Gorski, Morgan Rouprêt, Benoit Peyronnet, Chloé Le Cossec, Benjamin Granger, Eva Comperat, Olivier Cussenot, Raphaële Renard-Penna, and Pierre Mozer, “Accuracy of magnetic resonance imaging/ultrasound fusion targeted biopsies to diagnose clinical significant prostate cancer in enlarged compared to smaller prostates,” The Journal of Urology, 2015. View at Publisher · View at Google Scholar
  • Almudena Zapatero, Araceli Guerrero, Xavier Maldonado, Ana Alvarez, Carmen Gonzalez San Segundo, Maria Angeles Cabeza Rodríguez, Victor Macias, Agustí Pedro Olive, Francesc Casas, Ana Boladeras, Carmen Martín de Vidales, Maria Luisa Vazquez de la Torre, Salvador Villà, Aitor Perez de la Haza, and Felipe A Calvo, “High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial,” The Lancet Oncology, 2015. View at Publisher · View at Google Scholar
  • Xinyu Yang, M. Francesca Monn, Libo Liu, Yuli Liu, Jinwei Su, Tianjing Lyu, Yanqing Gong, Lisha Wang, Darrell D. Davidson, and Liang Cheng, “Incidental prostate cancer in Asian men: High prevalence of incidental prostatic adenocarcinoma in Chinese patients undergoing radical cystoprostatectomy for treatment of bladder cancer and selection of candidates for prostate-sparing cystectomy,” The Prostate, 2015. View at Publisher · View at Google Scholar
  • Henrique J. Cardoso, Cátia V. Vaz, Sara Correia, Marília I. Figueira, Ricardo Marques, Cláudio J. Maia, and Sílvia Socorro, “Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer,” The Prostate, 2015. View at Publisher · View at Google Scholar
  • Roque Diaz, Paul A. Nguewa, Miriam Redrado, Irene Manrique, and Alfonso Calvo, “Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem-like cells,” The Prostate, 2015. View at Publisher · View at Google Scholar
  • C. J. Paller, Y. M. Kanaan, D. A. Beyene, T. J. Naab, R. L. Copeland, H. L. Tsai, N. F. Kanarek, and T. S. Hudson, “Risk of prostate cancer in African-American men: Evidence of mixed effects of dietary quercetin by serum vitamin D status,” The Prostate, 2015. View at Publisher · View at Google Scholar
  • Kenneth C. Valkenburg, Galen Hostetter, and Bart O. Williams, “Concurrent Hepsin overexpression and adenomatous polyposis coli deletion causes invasive prostate carcinoma in mice,” The Prostate, 2015. View at Publisher · View at Google Scholar
  • Satoko Sato, Mika Watanabe, Shinji Taniuchi, Atsuko Kasajima, Koji Mitsuzuka, Yasuhiro Nakamura, Fumiyoshi Fujishima, Yoichi Arai, and Hironobu Sasano, “Precise Preoperative Localization of Prostate Cancer Employing 12-Core Needle Biopsy with a Tissue-Marking Method for Effective Surgical Strategy,” Tohoku Journal Of Experimental Medicine, vol. 236, no. 1, pp. 55–61, 2015. View at Publisher · View at Google Scholar
  • Seyed Hamid Aghaee-Bakhtiari, Ehsan Arefian, Mahmood Naderi, Farshid Noorbakhsh, Vahideh Nodouzi, Mojgan Asgari, Pezhman Fard-Esfahani, Reza Mahdian, and Masoud Soleimani, “MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches,” Tumor Biology, 2015. View at Publisher · View at Google Scholar
  • D. Baumunk, and M. Schostak, “Treatment of localized prostate cancer with high-intensity focused ultrasound,” Urologe, vol. 54, no. 2, pp. 183–190, 2015. View at Publisher · View at Google Scholar
  • Xiao Shen, and Wei-Qin Li, “High-mobility group box 1 protein and its role in severe acute pancreatitis,” World Journal Of Gastroenterology, vol. 21, no. 5, pp. 1424–1435, 2015. View at Publisher · View at Google Scholar
  • Jonas Busch, Mark L. Gonzalgo, Natalia Leva, Michelle Ferrari, Hannes Cash, Carsten Kempkensteffen, Stefan Hinz, Kurt Miller, and Ahmed Magheli, “Matched comparison of robotaEuroassisted, laparoscopic and open radical prostatectomy regarding pathologic and oncologic outcomes in obese patients,” World Journal Of Urology, vol. 33, no. 3, pp. 397–402, 2015. View at Publisher · View at Google Scholar
  • Taimur T. Shah, Veeru Kasivisvanathan, Charles Jameson, Alex Freeman, Mark Emberton, and Hashim U. Ahmed, “Histological outcomes after focal high-intensity focused ultrasound and cryotherapy,” World Journal Of Urology, vol. 33, no. 7, pp. 955–964, 2015. View at Publisher · View at Google Scholar
  • G. A. Gomez, P. F. Gutierrez, R. Lopez-Cubillana, and P. Lopez, “Is minimally invasive transanal surgery an alternative for rectal-urinary fistula correction?,” Actas Urologicas Espanolas, vol. 38, no. 4, pp. 276–277, 2014. View at Publisher · View at Google Scholar
  • Rose G. Radin, Shiriki K. Kumanyika, Edward A. Ruiz-Narvaez, Julie R. Palmer, and Lynn Rosenberg, “Prospective study of dietary fat and risk of uterine leiomyomata,” American Journal of Clinical Nutrition, vol. 99, no. 5, pp. 1105–1116, 2014. View at Publisher · View at Google Scholar
  • Youngyo Kim, and Youjin Je, “Dietary Fiber Intake and Total Mortality: A Meta-Analysis of Prospective Cohort Studies,” American Journal of Epidemiology, vol. 180, no. 6, pp. 565–573, 2014. View at Publisher · View at Google Scholar
  • Nathan A. Berger, “Obesity and cancer pathogenesis,” Annals of the New York Academy of Sciences, vol. 1311, no. 1, pp. 57–76, 2014. View at Publisher · View at Google Scholar
  • Edoardo Francini, Anna Ida Fiaschi, Roberto Petrioli, Filippo Francini, Vincenzo Bianco, Armando Perrella, Giovanni Paganini, Letizia Laera, and Giandomenico Roviello, “Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer,” Anti-Cancer Drugs, vol. 25, no. 4, pp. 472–477, 2014. View at Publisher · View at Google Scholar
  • Helen Blanchard, Khuchtumur Bum-Erdene, and Matthew W. Hugo, “Inhibitors of Galectins and Implications for Structure-Based Design of Galectin-Specific Therapeutics,” Australian Journal of Chemistry, vol. 67, no. 12, pp. 1763, 2014. View at Publisher · View at Google Scholar
  • Er-Jiang Lin, Xian Zhang, Da-Ya Wang, Shi-Zhe Hong, and Lei-Yu Li, “Naringenin modulates the metastasis of human prostate cancer cells by down regulating the matrix metalloproteinases-2/-9 via ROS/ERK1/2 pathways,” Bangladesh Journal of Pharmacology, vol. 9, no. 3, pp. 419–427, 2014. View at Publisher · View at Google Scholar
  • Katsura Kakoki, Haruka Kamiyama, Mai Izumida, Yuka Yashima, Hideki Hayashi, Naoki Yamamoto, Toshifumi Matsuyama, Tsukasa Igawa, Hideki Sakai, and Yoshinao Kubo, “Androgen-independent proliferation of LNCaP prostate cancer cells infected by xenotropic murine leukemia virus-related virus,” Biochemical and Biophysical Research Communications, 2014. View at Publisher · View at Google Scholar
  • Apollo D. Kacsinta, Cynthia S. Rubenstein, Isis C. Sroka, Sangita Pawar, Jaime M. Gard, Raymond B. Nagle, and Anne E. Cress, “Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines,” Biochemical and Biophysical Research Communications, 2014. View at Publisher · View at Google Scholar
  • Siegfried Wagner, Anaclet Ngezahayo, Hugo Murua Escobar, and Ingo Nolte, “ Role of miRNA Let-7 and Its Major Targets in Prostate Cancer ,” BioMed Research International, vol. 2014, pp. 1–14, 2014. View at Publisher · View at Google Scholar
  • Adam M. Hirst, Fiona M. Frame, Norman J. Maitland, and Deborah O’Connell, “Low Temperature Plasma: A Novel Focal Therapy for Localized Prostate Cancer?,” BioMed Research International, vol. 2014, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • Jan Tykvart, Jiří Schimer, Jitka Bařinková, Petr Pachl, Lenka Poštová-Slavětínská, Pavel Majer, Jan Konvalinka, and Pavel Šácha, “Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery,” Bioorganic & Medicinal Chemistry, 2014. View at Publisher · View at Google Scholar
  • Andrea R. Spence, Marie-Claude Rousseau, Pierre I. Karakiewicz, and Marie-Élise Parent, “Circumcision and prostate cancer: a population-based case-control study in Montréal, Canada,” BJU International, 2014. View at Publisher · View at Google Scholar
  • Gillian M. Duchesne, and Henry H. Woo, “The ‘Timing of Androgen-Deprivation therapy in incurable prostate cancer’ protocol (TOAD) - where are we now? Synopsis of the Victorian Cooperative Oncology Group PR 01-03 and Trans-Tasman Radiation Oncology Group 03.06 clinical trial,” BJU International, vol. 114, pp. 9–12, 2014. View at Publisher · View at Google Scholar
  • Guru Sonpavde, Christopher G. Wang, Matthew D. Galsky, William K. Oh, and Andrew J. Armstrong, “Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC),” BJU International, 2014. View at Publisher · View at Google Scholar
  • Haidar Abdul-Muhsin, Camilo Giedelman, Srinivas Samavedi, Oscar Schatloff, Rafael Coelho, Bernardo Rocco, Kenneth Palmer, George Ebra, and Vipul Patel, “Perioperative and early oncological outcomes after robot-assisted radical prostatectomy (RARP) in morbidly obese patients: a propensity score-matched ,” Bju International, vol. 113, no. 1, pp. 84–91, 2014. View at Publisher · View at Google Scholar
  • Ying Zhang, Thomas Perez, Beth Blondin, Jing Du, Ping Liu, Diana Escarzaga, John S. Coon, Larry E. Morrison, and Katerina Pestova, “Identification of FISH biomarkers to detect chromosome abnormalities associated with prostate adenocarcinoma in tumour and field effect environment,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Elina Korpela, Darren Yohan, Lee C. L. Chin, Anthony Kim, Xiaoyong Huang, Shachar Sade, Paul Van Slyke, Daniel J. Dumont, and Stanley K. Liu, “Vasculotide, an Angiopoietin-1 mimetic, reduces acute skin ionizing radiation damage in a preclinical mouse model,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Morten Beck Rye, Helena Bertilsson, Finn Drablos, Anders Angelsen, Tone F. Bathen, and May-Britt Tessem, “Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer,” Bmc Medical Genomics, vol. 7, 2014. View at Publisher · View at Google Scholar
  • Sigve Andersen, Elin Richardsen, Yngve Nordby, Nora Ness, Oystein Storkersen, Khalid Al-Shibli, Tom Donnem, Helena Bertilsson, Lill-Tove Busund, Anders Angelsen, and Roy M. Bremnes, “Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time,” Bmc Urology, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Kelvin A. Moses, Ling Y. Chen, Daniel D. Sjoberg, Melanie Bernstein, and Karim A. Touijer, “Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy,” Bmc Urology, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Brandon A. Mahal, David R. Ziehr, Andrew S. Hyatt, Emily H. Neubauer-Sugar, Desmond A. O'Farrell, Michael P. O'Leary, Graeme S. Steele, Thomas R. Niedermayr, Clair J. Beard, Neil E. Martin, Peter F. Orio, Anthony V. D'Amico, Phillip M. Devlin, and Paul L. Nguyen, “Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results,” Brachytherapy, 2014. View at Publisher · View at Google Scholar
  • Juanita Crook, “Long-term oncologic outcomes of radical prostatectomy compared with brachytherapy-based approaches for intermediate- and high-risk prostate cancer,” Brachytherapy, 2014. View at Publisher · View at Google Scholar
  • A Paziewska, M Dabrowska, K Goryca, A Antoniewicz, J Dobruch, M Mikula, D Jarosz, L Zapala, A Borowka, and J Ostrowski, “DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy,” British Journal of Cancer, 2014. View at Publisher · View at Google Scholar
  • M Shipitsin, C Small, S Choudhury, E Giladi, S Friedlander, J Nardone, S Hussain, A D Hurley, C Ernst, Y E Huang, H Chang, T P Nifong, D L Rimm, J Dunyak, M Loda, D M Berman, and P Blume-Jensen, “Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error,” British Journal of Cancer, 2014. View at Publisher · View at Google Scholar
  • Elizabeth J. Davis, Jennifer L. Beebe-Dimmer, Cecilia L. Yee, and Kathleen A. Cooney, “Risk of second primary tumors in men diagnosed with prostate cancer: A population-based cohort study,” Cancer, 2014. View at Publisher · View at Google Scholar
  • Lei Chang, Peter H. Graham, Jingli Hao, Joseph Bucci, Paul J. Cozzi, John H. Kearsley, and Yong Li, “Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy,” Cancer and Metastasis Reviews, 2014. View at Publisher · View at Google Scholar
  • Caryn E. Peterson, Garth H. Rauscher, Timothy P. Johnson, Carolyn V. Kirschner, Richard E. Barrett, Seijeoung Kim, Marian L. Fitzgibbon, Charlotte E. Joslin, and Faith G. Davis, “The association between neighborhood socioeconomic status and ovarian cancer tumor characteristics,” Cancer Causes & Control, 2014. View at Publisher · View at Google Scholar
  • Anu W. Turunen, Anna L. Suominen, Hannu Kiviranta, Pia K. Verkasalo, and Eero Pukkala, “Cancer incidence in a cohort with high fish consumption,” Cancer Causes & Control, 2014. View at Publisher · View at Google Scholar
  • D. Maxwell Parkin, Freddie Bray, Jacques Ferlay, and Ahmedin Jemal, “Cancer in Africa 2012,” Cancer Epidemiology Biomarkers & Prevention, vol. 23, no. 6, pp. 953–966, 2014. View at Publisher · View at Google Scholar
  • Emma H. Allott, Lauren E. Howard, Matthew R. Cooperberg, Christopher J. Kane, William J. Aronson, Martha K. Terris, Christopher L. Amling, and Stephen J. Freedland, “Serum Lipid Profile and Risk of Prostate Cancer Recurrence: Results from the SEARCH Database,” Cancer Epidemiology Biomarkers & Prevention, vol. 23, no. 11, pp. 2349–2356, 2014. View at Publisher · View at Google Scholar
  • Ramogomo Frans Matshela, Johanna E. Maree, and Corrien van Belkum, “Prevention and Detection of Prostate Cancer,” Cancer Nursing, vol. 37, no. 3, pp. 189–197, 2014. View at Publisher · View at Google Scholar
  • Xavier Moreel, Janie Allaire, Caroline Leger, Andre Caron, Marie-Eve Labonte, Benoit Lamarche, Pierre Julien, Patrice Desmeules, Bernard Tetu, and Vincent Fradet, “Prostatic and Dietary Omega-3 Fatty Acids and Prostate Cancer Progression during Active Surveillance,” Cancer Prevention Research, vol. 7, no. 7, pp. 766–776, 2014. View at Publisher · View at Google Scholar
  • Jason D. Morken, Aaron Packer, Rebecca A. Everett, John D. Nagy, and Yang Kuang, “Mechanisms of Resistance to Intermittent Androgen Deprivation in Patients with Prostate Cancer Identified by a Novel Computational Method,” Cancer Research, vol. 74, no. 14, pp. 3673–3683, 2014. View at Publisher · View at Google Scholar
  • Y. Liu, L. Zhao, Y. Ju, W. Li, M. Zhang, Y. Jiao, J. Zhang, S. Wang, Y. Wang, M. Zhao, B. Zhang, and Y. Zhao, “A novel androstenedione derivative induces ROS-mediated autophagy and attenuates drug resistance in osteosarcoma by inhibiting macrophage migration inhibitory factor (MIF),” Cell Death & Disease, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Guan-yuan Chen, Huai-hsuan Chiu, Shu-wen Lin, Yufeng Jane Tseng, Sung-jeng Tsai, and Ching-hua Kuo, “Development and application of a comparative fatty acid analysis method to investigate voriconazole-induced hepatotoxicity,” Clinica Chimica Acta, 2014. View at Publisher · View at Google Scholar
  • Renato A. Valdés Olmos, Daphne D. D. Rietbergen, and Sergi Vidal-Sicart, “SPECT/CT and sentinel node lymphoscintigraphy,” Clinical and Translational Imaging, 2014. View at Publisher · View at Google Scholar
  • G. Liu, D. Shen, L. Jiao, and Y. Sun, “Nin one binding protein expression as a prognostic marker in prostate carcinoma,” Clinical and Translational Oncology, 2014. View at Publisher · View at Google Scholar
  • Masaki Shiota, Akira Yokomizo, Ario Takeuchi, Kenjiro Imada, Eiji Kashiwagi, YooHyun Song, Junichi Inokuchi, Katsunori Tatsugami, Takeshi Uchiumi, and Seiji Naito, “Inhibition of Protein Kinase C/Twist1 Signaling Augments Anticancer Effects of Androgen Deprivation and Enzalutamide in Prostate Cancer,” Clinical Cancer Research, vol. 20, no. 4, pp. 951–961, 2014. View at Publisher · View at Google Scholar
  • Alexander E. Rand, Ankit Agarwal, Divya Ahuja, Taylor Ngo, Muhammad M. Qureshi, Apar Gupta, and Ariel E. Hirsch, “Patient demographics and disease stage as drivers of disparities in mortality in prostate cancer patients receiving care at a safety net academic medical center,” Clinical Genitourinary Cancer, 2014. View at Publisher · View at Google Scholar
  • Alexander E. Rand, Ankit Agarwal, Divya Ahuja, Taylor Ngo, Muhammad M. Qureshi, Apar Gupta, and Ariel E. Hirsch, “Patient Demographic Characteristics and Disease Stage as Drivers of Disparities in Mortality in Prostate Cancer Patients Who Receive Care at a Safety Net Academic Medical Center,” Clinical Genitourinary Cancer, vol. 12, no. 6, pp. 455–460, 2014. View at Publisher · View at Google Scholar
  • A.C. Tree, V.S. Khoo, N.J. van As, and M. Partridge, “Is Biochemical Relapse-free Survival After Profoundly Hypofractionated Radiotherapy Consistent with Current Radiobiological Models?,” Clinical Oncology, 2014. View at Publisher · View at Google Scholar
  • C Grenade, M A Phelps, and M A Villalona-Calero, “Race and Ethnicity in Cancer Therapy: What Have We Learned?,” Clinical Pharmacology & Therapeutics, 2014. View at Publisher · View at Google Scholar
  • Bernhard Ralla, Carsten Stephan, Sebastian Meller, Dimo Dietrich, Glen Kristiansen, and Klaus Jung, “Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies*,” Critical Reviews in Clinical Laboratory Sciences, pp. 1–32, 2014. View at Publisher · View at Google Scholar
  • Edward Ottley, and Elspeth Gold, “microRNA and non-canonical TGF-βsignalling: implications for prostate cancer therapy,” Critical Reviews in Oncology/Hematology, 2014. View at Publisher · View at Google Scholar
  • Doreen Pon, Andrew Abe, and Eric K. Gupta, “A Review of Statin Use and Prostate Cancer,” Current Atherosclerosis Reports, vol. 17, no. 2, 2014. View at Publisher · View at Google Scholar
  • H. Robert Superko, Alex R. Superko, Gina P. Lundberg, Basil Margolis, Brenda C. Garrett, Khurram Nasir, and Arthur S. Agatston, “Omega-3 Fatty Acid Blood Levels Clinical Significance Update,” Current Cardiovascular Risk Reports, vol. 8, no. 11, 2014. View at Publisher · View at Google Scholar
  • Cat N. Bui, Li Wang, and Onur Baser, “Resource utilization and use of life-extending therapies and corticosteroids in prostate cancer patients with corticosteroid-sensitive comorbidities,” Current Medical Research and Opinion, pp. 1–30, 2014. View at Publisher · View at Google Scholar
  • Philip C. Calder, and Richard J. Deckelbaum, “Dietary fatty acids in health and disease,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 17, no. 2, pp. 111–115, 2014. View at Publisher · View at Google Scholar
  • C. Mary Schooling, “Testosterone and cardiovascular disease,” Current Opinion in Endocrinology & Diabetes and Obesity, vol. 21, no. 3, pp. 202–208, 2014. View at Publisher · View at Google Scholar
  • Ulka Vaishampayan, “Therapeutic options and multifaceted treatment paradigms in metastatic castrate-resistant prostate cancer,” Current Opinion in Oncology, vol. 26, no. 3, pp. 265–273, 2014. View at Publisher · View at Google Scholar
  • Lauren E. Holz, and Michael Goodman, “Epidemiology of advanced prostate Cancer: Overview of known and less Explored Disparities in prostate Cancer prognosis,” Current Problems in Cancer, 2014. View at Publisher · View at Google Scholar
  • Rajan T. Gupta, Thomas J. Polascik, Samir S. Taneja, and Andrew B. Rosenkrantz, “Recent Developments in Multiparametric Prostate MR Imaging,” Current Radiology Reports, vol. 2, no. 12, 2014. View at Publisher · View at Google Scholar
  • B. Beyer, K. Kühne, K. Böhm, J. Schiffmann, H. Heinzer, U. Michl, H. Huland, M. Graefen, A. Haese, and T. Steuber, “Roboterassistierte radikale Prostatektomie,” Der Urologe, 2014. View at Publisher · View at Google Scholar
  • D. Küllenberg de Gaudry, and U. Massing, “Stellenwert von langkettigen Omega-3-Fettsäuren bei Prostatakrebs,” Der Urologe, 2014. View at Publisher · View at Google Scholar
  • Michael J. Solomon, Ker-Kan Tan, Richard Gideon Bromilow, and James C. H. Wong, “Bilateral Puborectalis Interposition Repair of Rectourethral Fistula,” Diseases of the Colon & Rectum, vol. 57, no. 1, pp. 133–139, 2014. View at Publisher · View at Google Scholar
  • Matt Shirley, and Paul L. McCormack, “Radium-223 Dichloride: A Review of Its Use in Patients with Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases,” Drugs, 2014. View at Publisher · View at Google Scholar
  • A. S. Cheung, J. D. Zajac, and M. Grossmann, “Muscle and bone effects of androgen deprivation therapy: current and emerging therapies,” Endocrine Related Cancer, vol. 21, no. 5, pp. R371–R394, 2014. View at Publisher · View at Google Scholar
  • Penelope D. Ottewell, Ning Wang, Joshua Meek, C. Anne Fowles, Peter I. Croucher, Colby L. Eaton, and Ingunn Holen, “Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone,” Endocrine-Related Cancer, vol. 21, no. 5, pp. 769–781, 2014. View at Publisher · View at Google Scholar
  • Luke A. Selth, Matthew J. Roberts, Clement W. K. Chow, Villis R. Marshall, Suhail A. R. Doi, Andrew D. Vincent, Lisa M. Butler, Martin F. Lavin, Wayne D. Tilley, and Robert A. Gardiner, “Human seminal fluid as a source of prostate cancer-specific microRNA biomarkers,” Endocrine-Related Cancer, vol. 21, no. 4, pp. L17–L21, 2014. View at Publisher · View at Google Scholar
  • Maria D. Roman, Camila Niclis, Natalia Tumas, Maria del Pilar Diaz, Alberto R. Osella, and Sonia E. Munoz, “Tobacco smoking patterns and differential food effects on prostate and breast cancers among smokers and nonsmokers in Cordoba, Argentina,” European Journal of Cancer Prevention, vol. 23, no. 4, pp. 310–318, 2014. View at Publisher · View at Google Scholar
  • Gijs H. KleinJan, Nynke S. van den Berg, Oscar R. Brouwer, Jeroen de Jong, Cenk Acar, Esther M. Wit, Erik Vegt, Vincent van der Noort, Renato A. Valdes Olmos, Fijs W. B. van Leeuwen, and Henk G. van der Poel, “Optimisation of Fluorescence Guidance During Robot-assisted Laparoscopic Sentinel Node Biopsy for Prostate Cancer,” European Urology, vol. 66, no. 6, pp. 991–998, 2014. View at Publisher · View at Google Scholar
  • Francesco Ricci, Giulia Buzzatti, Alessandra Rubagotti, and Francesco Boccardo, “Safety of antiandrogen therapy for treating prostate cancer,” Expert Opinion on Drug Safety, vol. 13, no. 11, pp. 1483–1499, 2014. View at Publisher · View at Google Scholar
  • Stavros Sfoungaristos, Stephen J Frank, Mordechai Duvdevani, Ofer N Gofrit, Vladimir Yutkin, Ran Katz, Dov Pode, and Petros Perimenis, “Contemporary pharmacotherapy for the prevention of skeletal complications in patients with prostate cancer,” Expert Opinion on Pharmacotherapy, pp. 1–12, 2014. View at Publisher · View at Google Scholar
  • Pedro Costa-Pinheiro, Rui Henrique, and Carmen Jerónimo, “Biomarkers and personalized risk stratification for patients with clinically localized prostate cancer,” Expert Review of Anticancer Therapy, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  • Taimur Tariq Shah, Hashim Ahmed, Abi Kanthabalan, Benjamin Lau, Maneesh Ghei, Barry Maraj, and Manit Arya, “Focal cryotherapy of localized prostate cancer: a systematic review of the literature,” Expert Review of Anticancer Therapy, vol. 14, no. 11, pp. 1337–1347, 2014. View at Publisher · View at Google Scholar
  • Angelo Rodrigues, Rui Freitas, Pedro Nogueira-Silva, Carmen Jeronimo, and Rui Henrique, “Biopsy sampling and histopathological markers for diagnosis of prostate cancer,” Expert Review of Anticancer Therapy, vol. 14, no. 11, pp. 1323–1336, 2014. View at Publisher · View at Google Scholar
  • Lin Wang, Suling Li, and Qunyu Gao, “Effect of Resistant Starch as Dietary Fiber Substitute on Cookies Quality Evaluation,” Food Science and Technology Research, vol. 20, no. 2, pp. 263–272, 2014. View at Publisher · View at Google Scholar
  • Johanna Pflaum, Sophie Schlosser, and Martina Müller, “p53 Family and Cellular Stress Responses in Cancer,” Frontiers in Oncology, vol. 4, 2014. View at Publisher · View at Google Scholar
  • Sankar N Krishna, and Raymond C Bergan, “Therapeutic modulation of prostate cancer metastasis,” Future Medicinal Chemistry, vol. 6, no. 2, pp. 223–239, 2014. View at Publisher · View at Google Scholar
  • Manish K Pant, Ahmed Abughaban, and Jeanny B Aragon-Ching, “Advances in systemic therapies for metastatic castration-resistant prostate cancer,” Future Oncology, vol. 10, no. 14, pp. 2213–2226, 2014. View at Publisher · View at Google Scholar
  • Julio Fernandez-Banet, Nikki P. Lee, Kin Tak Chan, Huan Gao, Xiao Liu, Wing Kin Sung, Winnie Tan, Sheung Tat Fan, Ronnie T. Poon, Shiyong Li, Keith Ching, Paul Rejto, Mao Mao, and Zhengyan Kan, “Decoding Complex Patterns of Genomic Rearrangement in Hepatocellular Carcinoma,” Genomics, 2014. View at Publisher · View at Google Scholar
  • Marci J Clark, Nimanee Harris, Ingolf Griebsch, Dagmar Kaschinski, and Catherine Copley-Merriman, “Patient-reported outcome labeling claims and measurement approach for metastatic castration-resistant prostate cancer treatments in the United States and European Union,” Health and Quality of Life Outcomes, vol. 12, no. 1, pp. 104, 2014. View at Publisher · View at Google Scholar
  • D. L. Ribeiro, R. M. Goes, M. E. Pinto-Fochi, S. R. Taboga, P. -A. Abrahamsson, and N. Dizeyi, “AKT and AMPK Activation after High-Fat and High-Glucose In Vitro Treatment of Prostate Epithelial Cells,” Hormone and Metabolic Research, vol. 46, no. 7, pp. 471–476, 2014. View at Publisher · View at Google Scholar
  • Madhuwanti Srinivasan, Souresh Banerjee, Allison Palmer, Guoxing Zheng, Aoshuang Chen, Maarten C. Bosland, André Kajdacsy-Balla, Ramaswamy Kalyanasundaram, and Gnanasekar Munirathinam, “HMGB1 in Hormone-Related Cancer: a Potential Therapeutic Target,” Hormones and Cancer, 2014. View at Publisher · View at Google Scholar
  • Kenneth A. Iczkowski, Kathleen C. Torkko, R. Storey Wilson, M. Scott Lucia, and David G. Bostwick, “Prostatic atrophy: its spatial proximity to carcinoma and intraepithelial neoplasia based on annotation of digital slides,” Human Pathology, vol. 45, no. 1, pp. 54–58, 2014. View at Publisher · View at Google Scholar
  • Jie Liu, Shuai Hu, Yun Cui, Meng-Kui Sun, Feng Xie, Qian Zhang, and Jie Jin, “Saturated Fatty Acids Up-regulate COX-2 Expression in Prostate Epithelial Cells via Toll-like Receptor 4/NF-kappa B Signaling,” Inflammation, vol. 37, no. 2, pp. 467–477, 2014. View at Publisher · View at Google Scholar
  • Fabio J. Pacheco, Frankis G. Almaguel, Whitney Evans, Leslimar Rios-Colon, Valery Filippov, Lai S. Leoh, Elizabeth Rook-Arena, Melanie Mediavilla-Varela, Marino De Leon, and Carlos A. Casiano, “Docosahexanoic acid antagonizes TNF-α-induced necroptosis by attenuating oxidative stress, ceramide production, lysosomal dysfunction, and autophagic features,” Inflammation Research, 2014. View at Publisher · View at Google Scholar
  • Tobin J. Strom, Sean Z. Hutchinson, Kushagra Shrinath, Alex A. Cruz, Nicholas B. Figura, Kevin Nethers, Matthew C. Biagioli, Daniel C. Fernandez, Randy V. Heysek, and Richard B. Wilder, “External beam radiation therapy and a low-dose-rate brachytherapy boost without or with androgen deprivation therapy for prostate cancer,” International Braz J Urol, vol. 40, no. 4, pp. 474–483, 2014. View at Publisher · View at Google Scholar
  • Yongqiang Chen, Lu Zheng, Junquan Liu, Zhonghai Zhou, Xiliang Cao, Xiaoting Lv, and Fuxing Chen, “Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways,” International Immunopharmacology, 2014. View at Publisher · View at Google Scholar
  • Barbara Kahn, Joanne Collazo, and Natasha Kyprianou, “Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer,” International Journal of Biological Sciences, vol. 10, no. 6, pp. 588–595, 2014. View at Publisher · View at Google Scholar
  • I. D. White, J. Wilson, P. Aslet, A. B. Baxter, A. Birtle, B. Challacombe, J. Coe, L. Grover, H. Payne, S. Russell, V. Sangar, N. Van As, and M. Kirby, “Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer,” International Journal of Clinical Practice, 2014. View at Publisher · View at Google Scholar
  • Arunee Hematulin, Daniel Sagan, Kanlayanee Sawanyawisuth, Wunchana Seubwai, and Sopit Wongkham, “Association between cellular radiosensitivity and G1/G2 checkpoint proficiencies in human cholangiocarcinoma cell lines,” International Journal of Oncology, vol. 45, no. 3, pp. 1159–1166, 2014. View at Publisher · View at Google Scholar
  • Bryan Hoang, Mark J. Ernsting, Mami Murakami, Elijus Undzys, and Shyh-Dar Li, “Docetaxel-carboxymethylcellulose nanoparticles display enhanced anti-tumor activity in murine models of castration-resistant prostate cancer,” International Journal of Pharmaceutics, vol. 471, no. 1-2, pp. 224–233, 2014. View at Publisher · View at Google Scholar
  • Bregje van Oorschot, Suzanne E. Hovingh, Perry D. Moerland, Jan Paul Medema, Lukas J.A. Stalpers, Harry Vrieling, and Nicolaas A.P. Franken, “Reduced Activity of Double-Strand Break Repair Genes in Prostate Cancer Patients With Late Normal Tissue Radiation Toxicity,” International Journal of Radiation Oncology*Biology*Physics, 2014. View at Publisher · View at Google Scholar